Fending Off The “Fallback”: Medicare Rx Bans Marketing Of Backup Plans
Executive Summary
Marketing restrictions on contractors offering "fallback" prescription drug plans under Medicare are one reason drug manufacturers are comfortable that the program will not evolve into a government administered benefit
You may also be interested in...
Broad Medicare Formularies Would Negatively Impact Rx Industry – PCMA
Strict formulary requirements imposed on plan sponsors under the Medicare prescription drug benefit would be self-defeating for pharmaceutical manufacturers, Pharmaceutical Care Management Association CEO Mark Merritt argued Oct. 25
Broad Medicare Formularies Would Negatively Impact Rx Industry – PCMA
Strict formulary requirements imposed on plan sponsors under the Medicare prescription drug benefit would be self-defeating for pharmaceutical manufacturers, Pharmaceutical Care Management Association CEO Mark Merritt argued Oct. 25
Medicare Rx “Fallback” Plans Ensured Small Role Under CMS Rule
Entities administering a Medicare prescription drug "fallback" plan in a single U.S. region will be prohibited from bidding as stand-alone PDPs anywhere nationwide during the three-year contract term, CMS' proposed regulation says